Connecticut-based Philip Morris opens $1.2 billion Zyn plant in Colorado
Article excerpt
Stacey Kennedy, CEO of Philip Morris International's U.S. operations, speaks in July 2026 in Aurora, Colo., where PMI opened its newly built manufacturing facility in the United States. PMI has its headquarters in Stamford, Conn. Philip Morris International's new manufacturing campus in Aurora, Colo., with production commencing in July at 5060 Harvest Road, about 5 miles south of Denver International Airport. Philip Morris International employees working at the company's new Zyn nicotine pouch manufacturing plant in Aurora, Colo., which commenced operations in July 2026. A Zyn nicotine pouch production line at Philip Morris International's new manufacturing plant in Aurora, Colora., which commenced operation in July 2026. Philip Morris International opened what it calls its first "greenfield" manufacturing plant built in the United States, a $1.2 billion facility in Colorado that will employ 500 workers about 5 miles south of Denver International Airport. PMI has its headquarters in Stamford, entering this year with a global employee base of 84,900 people. Earnings totaled $3 billion in the second quarter on revenue of $11.2 billion, a 10% increase from a year earlier. PMI is making Zyn nicotine pouches in Aurora, Colo., adding to existing U.S. plants in Kentucky and North Carolina and a Zyn plant in Sweden. Last month, the U.S...
Keep reading with a free account
The rest of this article, and every signal for Philip Morris, is in your free account.
Extracted from this sentence
PMI is currently restructuring its U.S. operations, including the planned closure of an office in Richmond, Va., and the transfer of some of those roles to Stamford and a newly established office in Tampa, Fla.
